Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Valvular Heart Disease

  Free Subscription


15.08.2022

3 Am J Cardiol
4 Ann Thorac Surg
5 Circulation
1 Clin Cardiol
5 Int J Cardiol
4 J Am Coll Cardiol
6 J Am Soc Echocardiogr
1 J Card Surg
1 Mayo Clin Proc
1 Semin Thorac Cardiovasc Surg


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. BANSAL A, Sankar PR, Kalra A, Puri R, et al
    Association of Hypertrophic Cardiomyopathy and Outcomes After Transcatheter Edge-to-Edge Mitral Valve Repair.
    Am J Cardiol. 2022 Aug 6. pii: S0002-9149(22)00732.
    PubMed        

  2. WOHRLE J, Gilard M, Didier R, Kini A, et al
    Outcomes After Transcatheter Aortic Valve Implantation in Men Versus Women.
    Am J Cardiol. 2022 Aug 4. pii: S0002-9149(22)00711.
    PubMed         Abstract available

  3. MIYASHITA H, Moriyama N, Dahlbacka S, Vahasilta T, et al
    Ultrasound-Guided Versus Conventional MANTA Vascular Closure Device Deployment After Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2022 Aug 3. pii: S0002-9149(22)00712.
    PubMed         Abstract available


    Ann Thorac Surg

  4. BOUCHAT M, Pelce E, Porto A, Badaoui R, et al
    Incidence of persistent left bundle branch block after rapid-deployment aortic valve replacement.
    Ann Thorac Surg. 2022 Aug 8. pii: S0003-4975(22)01081.
    PubMed         Abstract available

  5. STROBEL RJ, Sahli ZT, Mehaffey JH, Hawkins RB, et al
    Appropriateness of Surgical Aortic Valve Replacement for Severe Aortic Stenosis is Increasing.
    Ann Thorac Surg. 2022 Aug 7. pii: S0003-4975(22)01079.
    PubMed         Abstract available

  6. HOFFMAN D, Odell JA
    Transventricular Mitral Valvotomy.
    Ann Thorac Surg. 2022 Aug 6. pii: S0003-4975(22)01082.
    PubMed        

  7. DOKOLLARI A, Sicouri S, Torregrossa G, Ramlawi B, et al
    Conduction Block after Rapid-deployment Aortic Valve Replacemen.
    Ann Thorac Surg. 2022 Aug 6. pii: S0003-4975(22)01083.
    PubMed        


    Circulation

  8. BANOVIC M, Putnik S, Iung B, Bartunek J, et al
    Response by Banovic et al to Letter Regarding Article, "Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial".
    Circulation. 2022;146:e48-e49.
    PubMed        

  9. ENNEZAT PV, Malergue MC, Abergel E
    Letter by Ennezat et al Regarding Article, "Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial".
    Circulation. 2022;146:e44-e45.
    PubMed        

  10. DWECK MR, Dahl JS
    Letter by Dweck and Dahl Regarding Article, "Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial".
    Circulation. 2022;146:e46-e47.
    PubMed        

  11. MAKKAR R, Chakravarty T
    Missing Pieces of the Transcatheter Aortic Valve Replacement Subclinical Leaflet Thrombosis Puzzle.
    Circulation. 2022;146:494-497.
    PubMed        

  12. PARK DW, Ahn JM, Kang DY, Kim KW, et al
    Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial.
    Circulation. 2022 Apr 4. doi: 10.1161/CIRCULATIONAHA.122.059512.
    PubMed         Abstract available


    Clin Cardiol

  13. WALPOT J, van Herck P, Collas V, Bossaerts L, et al
    Adiponectin serum level is an independent and incremental predictor of all-cause mortality after transcatheter aortic valve replacement.
    Clin Cardiol. 2022 Aug 6. doi: 10.1002/clc.23892.
    PubMed         Abstract available


    Int J Cardiol

  14. FISCHLEIN T, Caporali E, Folliguet T, Kappert U, et al
    Randomized controlled trial between conventional versus sutureless bioprostheses for aortic valve replacement: Impact of mini and full sternotomy access at 1-year follow-up.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01179.
    PubMed         Abstract available

  15. MUSICANTE M, Kim HH, Chen Y, Liao F, et al
    Regulation of endothelial nitric oxide synthase in cardiac remodeling.
    Int J Cardiol. 2022;364:96-101.
    PubMed         Abstract available

  16. SCOTTI A, Sturla M, Coisne A, Assafin M, et al
    Monitoring conduction disturbances following TAVR: Feasibility study of early discharge using a novel telemetry patch.
    Int J Cardiol. 2022;364:35-37.
    PubMed         Abstract available

  17. ANDREASSEN K, Dejgaard LA, Lie O, Fink TS, et al
    Exercise training during childhood and adolescence is associated with favorable diastolic function in hypertrophic cardiomyopathy.
    Int J Cardiol. 2022;364:65-71.
    PubMed         Abstract available

  18. ALI LA, Marrone C, Martins DS, Khraiche D, et al
    Prognostic factors in hypertrophic cardiomyopathy in children: An MRI based study.
    Int J Cardiol. 2022;364:141-147.
    PubMed         Abstract available


    J Am Coll Cardiol

  19. CHURCHILL TW, Yucel E, Deferm S, Levine RA, et al
    Mitral Valve Dysfunction in Patients With Annular Calcification: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;80:739-751.
    PubMed         Abstract available

  20. HAYASHIDA K
    Transcatheter Valve Treatment for a Failed Small Surgical Aortic Valve: Addressing the Achilles' Heel.
    J Am Coll Cardiol. 2022;80:694-696.
    PubMed        

  21. OH JK, Ito S
    Severity of Aortic Stenosis: A Moving Target.
    J Am Coll Cardiol. 2022;80:677-680.
    PubMed        

  22. STASSEN J, Ewe SH, Singh GK, Butcher SC, et al
    Prevalence and Prognostic Implications of Discordant Grading and Flow-Gradient Patterns in Moderate Aortic Stenosis.
    J Am Coll Cardiol. 2022;80:666-676.
    PubMed         Abstract available


    J Am Soc Echocardiogr

  23. STRACHINARU M, Huurman R, Bowen DJ, Schinkel AFL, et al
    Relation Between Early Diastolic Mid-Ventricular Flow and Elastic Forces Indicating Aneurysm Formation in Hypertrophic Cardiomyopathy.
    J Am Soc Echocardiogr. 2022;35:846-856.
    PubMed         Abstract available

  24. HOUSE CM, Nelson WB
    Questions Regarding a Recent Study Comparing Mitral Regurgitant Volume Between Proximal Flow Convergence and Volumetric Methods: The Importance of Sex Differences.
    J Am Soc Echocardiogr. 2022;35:888.
    PubMed        

  25. NGUYEN MB, Dragulescu A, Chaturvedi R, Fan CS, et al
    Understanding Complex Interactions in Pediatric Diastolic Function Assessment.
    J Am Soc Echocardiogr. 2022;35:868-877.
    PubMed         Abstract available

  26. CORREA A, Joshi AA, Argulian E
    Three-dimensional echocardiographic evaluation of indentations of the posterior mitral leaflet and their impact on secondary mitral regurgitation.
    J Am Soc Echocardiogr. 2022 Aug 9. pii: S0894-7317(22)00406.
    PubMed        

  27. ABDELGHANI M, Ezzat A, Elsheikh H, Attia WM, et al
    Multi-Perspective Three-dimensional Transthoracic Echocardiographic Assessment of Mitral Valve Area in Patients with Rheumatic Mitral Stenosis.
    J Am Soc Echocardiogr. 2022 Aug 8. pii: S0894-7317(22)00404.
    PubMed        

  28. GARDIN JM
    Letter to the Editor - Rationale for Using Multiple Echo-Doppler Methods to Quantify Mitral Regurgitation.
    J Am Soc Echocardiogr. 2022 Aug 4. pii: S0894-7317(22)00388.
    PubMed        


    J Card Surg

  29. DRAKOPOULOU M, Latsios G, Synetos A, Benetos G, et al
    Transcatheter mitral valve-in-valve replacement transeptally using a novel balloon-expandable device.
    J Card Surg. 2022 Aug 10. doi: 10.1111/jocs.16819.
    PubMed         Abstract available


    Mayo Clin Proc

  30. LARA-BREITINGER KM, Scott CG, Nkomo VT, Pellikka PA, et al
    Tricuspid Regurgitation Impact on Outcomes (TRIO): A Simple Clinical Risk Score.
    Mayo Clin Proc. 2022;97:1449-1461.
    PubMed         Abstract available


    Semin Thorac Cardiovasc Surg

  31. SCHULZ A, Taylor L, Buratto E, Ivanov Y, et al
    Aortic valve repair in neonates with aortic stenosis and reduced left ventricular function.
    Semin Thorac Cardiovasc Surg. 2022 Aug 3. pii: S1043-0679(22)00195.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: